|
1
|
Pinals RS: Survival in rheumatoid
arthritis. Arthritis Rheum. 30:473–475. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Turhanoglu AD, Guler H, Yonden Z, Aslan F,
Mansuroglu A and Ozer C: The relationship between vitamin D and
disease activity and functional health status in RA. Rheumatol Int.
31:911–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Prietl B, Treiber G, Pieber TR and Amrein
K: Vitamin D and immune function. Nutrients. 5:2502–2521. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen S, Sims GP, Chen XX, Gu YY, Chen S
and Lipsky PE: Modulatory effects of 1,25-dihydroxyvitamin D3 on
human B cell differentiation. J Immunol. 179:1634–1647. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Craig SM, Yu F, Curtis JR, Alarcón GS,
Conn DL, Jonas B, Callahan LF, Smith EA, Moreland LW, Bridges SL
Jr, et al: Vitamin D status and its associations with disease
activity and severity in African Americans with recent-onset RA. J
Rheumatol. 37:275–281. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang M, Chen D, Lou Y and Wan R:
Association study between 25(OH) vitamin D and early RA. Lab Med
Clin. 7:1076–1077. 2010.
|
|
7
|
Aletaha D, Neogi T, Silman AJ, Funovits J,
Felson DT, Bingham CO III, Birnbaum NS, Burmester GR, Bykerk VP,
Cohen MD, et al: 2010 rheumatoid arthritis classification criteria:
an American College of Rheumatology/European League Against
Rheumatism collaborative initiative. Ann Rheum Dis. 69:1580–1588.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Haque UJ and Bartlett SJ: Relationships
among vitamin D, disease activity, pain and disability in RA. Clin
Exp Rheumatol. 28:745–747. 2010.PubMed/NCBI
|
|
9
|
Tetlow LC and Woolley DE: The effects of 1
alpha,25-dihydroxyvitamin D(3) on matrix metalloproteinase and
prostaglandin E(2) production by cells of the rheumatoid lesion.
Arthritis Res. 1:63–70. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cutolo M, Otsa K, Laas K, Yprus M, Lehtme
R, Secchi ME, Sulli A, Paolino S and Seriolo B: Circannual vitamin
D serum levels and disease activity in RA: Northern versus Southern
Europe. Clin Exp Rheumatol. 24:702–704. 2006.PubMed/NCBI
|
|
11
|
May E, Asadullah K and Zügel U:
Immunoregulation through 1,25-dihydroxyvitamin D3 and its analogs.
Curr Drug Targets Inflamm Allergy. 3:377–393. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Andjelkovic Z, Vojinovic J, Pejnovic N,
Popovic M, Dujic A, Mitrovic D, Pavlica L and Stefanovic D: Disease
modifying and immunomodulatory effects of high dose 1 alpha (OH) D3
in RA patients. Clin Exp Rheumatol. 17:453–456. 1999.PubMed/NCBI
|
|
13
|
Merlino LA, Curtis J, Mikuls TR, Cerhan
JR, Criswell LA and Saag KG: Iowa Womens Health Study: Vitamin D
intake is inversely associated with RA: results from the Iowa
Women's Health Study. Arthritis Rheum. 50:72–77. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Patel S, Farragher T, Berry J, Bunn D,
Silman A and Symmons D: Association between serum vitamin D
metabolite levels and disease activity in patients with early
inflammatory polyarthritis. Arthritis Rheum. 56:2143–2149. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kröger H, Penttilä IM and Alhava EM: Low
serum vitamin D metabolites in women with RA. Scand J Rheumatol.
22:172–177. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Andjelkovic Z, Vojinovic J, Pejnovic N,
Popovic M, Dujic A, Mitrovic D, Pavlica L and Stefanovic D: Disease
modifying and immunomodulatory effects of high dose 1a(OH)D3 in RA
patients. Clin Exp Rheumatol. 17:453–456. 1999.PubMed/NCBI
|
|
17
|
Harel M and Shoenfeld Y: Predicting and
preventing autoimmunity, myth or reality? Ann NY Acad Sci.
1069:322–345. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dehghan A, Rahimpour S,
Soleymani-Salehabadi H and Owlia MB: Role of vitamin D in flare ups
of rheumatoid arthritis. Z Rheumatol. 73:461–464. 2014. View Article : Google Scholar : PubMed/NCBI
|
